|
In a significant move to curb illicit substance distribution, a joint enforcement operation led by the Prohibition and Excise Department and the Drugs Control Administration of Telangana has successfully uncovered a large-scale unauthorized stockpile of psychotropic substances.
The raid took place last Tuesday, at Hyma Synthesis Pvt. Ltd., located in the IDA Nacharam area of the Medchal-Malkajgiri District. The inspection team discovered that the facility was in unauthorized possession of N-benzylpiperazine (BZP). This substance is explicitly notified under the Narcotic Drugs and Psychotropic Substances (NDPS) Act of 1985 and is classified within Schedule I of the corresponding rules.
Beyond the illegal possession of the substance, investigators uncovered critical regulatory failures at the firm. The company failed to maintain mandatory statutory records regarding the acquisition, utilization, and possession of this psychotropic substance, as required by Form 7 under Rule 67A of the NDPS Rules.
N-benzylpiperazine is a synthetic designer drug known for producing stimulant and euphoriant effects comparable to MDMA. Due to its potential for abuse as a recreational drug, it is strictly regulated; any unauthorized handling, including manufacture, sale, or transport, constitutes a serious, punishable offense under the NDPS Act.
During the course of the operation, authorities seized 5.850 kilograms of N-benzylpiperazine. The illicit market value of the confiscated cache is estimated to be approximately Rs. 1.58 crore.
Following these findings, the Prohibition and Excise Department has formally registered a case against the firm under Section 8(c) read with Section 22(c) of the NDPS Act, 1985. Officials have indicated that a thorough investigation is underway to identify and prosecute all individuals involved in these violations.
This joint enforcement effort was spearheaded by a team including DSP R Thirupathi Yadav and Circle Inspector Ch. Nagaraju of the Prohibition and Excise Department, alongside Drugs Inspectors G. Indira Priyadarshini and K. Anvesh from the Drugs Control Administration.
The departments have issued a stern warning that they will continue to pursue stringent actions against the illegal diversion and stocking of controlled substances to protect public health.
|